Global Gastrointestinal Cancer Drugs Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Gastrointestinal Cancer Drugs Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Oncology
  • 1.2.2 Radiology
  • 1.2.3 Others
• 1.3 Market Analysis by Applications
  • 1.3.1 Hospitals
  • 1.3.2 Specialized Cancer Treatment Centers
  • 1.3.3 Clinics
  • 1.3.4 Ambulatory Surgical Centers
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2013-2023)
    • 1.4.1.2 Canada Market States and Outlook (2013-2023)
    • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2013-2023)
    • 1.4.2.2 France Market States and Outlook (2013-2023)
    • 1.4.2.3 UK Market States and Outlook (2013-2023)
    • 1.4.2.4 Russia Market States and Outlook (2013-2023)
    • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2013-2023)
    • 1.4.3.2 Japan Market States and Outlook (2013-2023)
    • 1.4.3.3 Korea Market States and Outlook (2013-2023)
    • 1.4.3.4 India Market States and Outlook (2013-2023)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
    • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
    • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Amgen Limited & Amgen Ireland Limited
  • 2.1.1 Business Overview
  • 2.1.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.2 Bristol-Myers Squibb Company
  • 2.2.1 Business Overview
  • 2.2.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.3 F. Hoffmann-La Roche Ltd.
  • 2.3.1 Business Overview
  • 2.3.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.4 Eli Lilly and Company
  • 2.4.1 Business Overview
  • 2.4.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.5 Johnson & Johnson Private Limited
  • 2.5.1 Business Overview
  • 2.5.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.6 GlaxoSmithKline plc.
  • 2.6.1 Business Overview
  • 2.6.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 GlaxoSmithKline plc. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.7 Celgene Corporation
  • 2.7.1 Business Overview
  • 2.7.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.8 Pfizer Inc.
  • 2.8.1 Business Overview
  • 2.8.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Pfizer Inc. Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.9 Sanofi
  • 2.9.1 Business Overview
  • 2.9.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Sanofi Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.10 Novartis AG
  • 2.10.1 Business Overview
  • 2.10.2 Gastrointestinal Cancer Drugs Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Novartis AG Gastrointestinal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Gastrointestinal Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

• 3.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Manufacturer (2016-2017)
• 3.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Gastrointestinal Cancer Drugs Manufacturer Market Share in 2017
• 3.4 Market Competition Trend

4 Global Gastrointestinal Cancer Drugs Market Analysis by Regions

• 4.1 Global Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Regions (2013-2018)
• 4.2 North America Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 4.3 Europe Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 4.4 Asia-Pacific Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 4.5 South America Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 4.6 Middle East and Africa Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

5 North America Gastrointestinal Cancer Drugs by Countries

• 5.1 North America Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
  • 5.1.1 North America Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
• 5.2 United States Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 5.3 Canada Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 5.4 Mexico Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

6 Europe Gastrointestinal Cancer Drugs by Countries

• 6.1 Europe Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
  • 6.1.1 Europe Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
• 6.2 Germany Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 6.3 UK Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 6.4 France Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 6.5 Russia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 6.6 Italy Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

7 Asia-Pacific Gastrointestinal Cancer Drugs by Countries

• 7.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
  • 7.1.1 Asia-Pacific Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
• 7.2 China Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 7.3 Japan Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 7.4 Korea Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 7.5 India Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 7.6 Southeast Asia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

8 South America Gastrointestinal Cancer Drugs by Countries

• 8.1 South America Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
  • 8.1.1 South America Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
• 8.2 Brazil Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 8.3 Argentina Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 8.4 Colombia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

9 Middle East and Africa Gastrointestinal Cancer Drugs by Countries

• 9.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Countries
  • 9.1.1 Middle East and Africa Gastrointestinal Cancer Drugs Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Gastrointestinal Cancer Drugs Revenue and Market Share by Countries (2013-2018)
• 9.2 Saudi Arabia Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 9.3 UAE Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 9.4 Egypt Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 9.5 Nigeria Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)
• 9.6 South Africa Gastrointestinal Cancer Drugs Sales and Growth Rate (2013-2018)

10 Global Gastrointestinal Cancer Drugs Market Segment by Type

• 10.1 Global Gastrointestinal Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
  • 10.1.1 Global Gastrointestinal Cancer Drugs Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Gastrointestinal Cancer Drugs Revenue and Market Share by Type (2013-2018)
• 10.2 Oncology Sales Growth and Price
  • 10.2.1 Global Oncology Sales Growth (2013-2018)
  • 10.2.2 Global Oncology Price (2013-2018)
• 10.3 Radiology Sales Growth and Price
  • 10.3.1 Global Radiology Sales Growth (2013-2018)
  • 10.3.2 Global Radiology Price (2013-2018)
• 10.4 Others Sales Growth and Price
  • 10.4.1 Global Others Sales Growth (2013-2018)
  • 10.4.2 Global Others Price (2013-2018)

11 Global Gastrointestinal Cancer Drugs Market Segment by Application

• 11.1 Global Gastrointestinal Cancer Drugs Sales Market Share by Application (2013-2018)
• 11.2 Hospitals Sales Growth (2013-2018)
• 11.3 Specialized Cancer Treatment Centers Sales Growth (2013-2018)
• 11.4 Clinics Sales Growth (2013-2018)
• 11.5 Ambulatory Surgical Centers Sales Growth (2013-2018)

12 Gastrointestinal Cancer Drugs Market Forecast (2018-2023)

• 12.1 Global Gastrointestinal Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)
• 12.2 Gastrointestinal Cancer Drugs Market Forecast by Regions (2018-2023)
  • 12.2.1 North America Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
  • 12.2.2 Europe Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
  • 12.2.4 South America Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Gastrointestinal Cancer Drugs Market Forecast (2018-2023)
• 12.3 Gastrointestinal Cancer Drugs Market Forecast by Type (2018-2023)
  • 12.3.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Gastrointestinal Cancer Drugs Market Share Forecast by Type (2018-2023)
• 12.4 Gastrointestinal Cancer Drugs Market Forecast by Application (2018-2023)
  • 12.4.1 Global Gastrointestinal Cancer Drugs Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Gastrointestinal Cancer Drugs Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology